ABILIFY
ARIPIPRAZOLE
- Strength
- 2 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
Aripiprazole
Listed by Chartwell RX, LLC
- Strength
- 1 mg/mL
- Form
- Solution
- Route
- Oral
- Class
- Atypical Antipsychotic
What it contains
- Aripiprazole 1 mg/mL
FDA record
| Dosage form | Solution |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | ANDA — approved generic |
| NDC code | 62135-904 |
| FDA application | ANDA215595 |
| RxNorm concept | 485496 |
| Package sizes listed | 1 |
| Marketed since | October 2022 |
Other products containing Aripiprazole
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ABILIFY
ARIPIPRAZOLE
- Strength
- 5 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
ABILIFY
ARIPIPRAZOLE
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
ABILIFY
ARIPIPRAZOLE
- Strength
- 15 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
ABILIFY
ARIPIPRAZOLE
- Strength
- 10 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
ABILIFY
ARIPIPRAZOLE
- Strength
- 20 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
Abilify Asimtufii
Aripiprazole
- Strength
- 720 mg/2.4mL
- Form
- Injection, Suspension, Extended Release
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc
Abilify Asimtufii
Aripiprazole
- Strength
- 960 mg/3.2mL
- Form
- Injection, Suspension, Extended Release
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.